FTC Chair Seeks to Revive Insulin Case By Ending Recusal

Just days after the Federal Trade Commission's general counsel stayed its insulin price-fixing case against the country's biggest pharmacy benefits managers due to a lack of commissioners, at least one is...

Already a subscriber? Click here to view full article